Background: Mechanisms of therapeutic change are rarely studied in child and adolescent
therapy. Our central thesis is that the study of mechanisms of treatment is an excellent …

Abstract On April 4, 2019, the FDA approved a supplemental new drug application for
palbociclib (IBRANCE), to expand the approved indications in women with hormone …

Breast cancer in men is a rare disease, accounting for∼ 1% of all breast cancer cases.
Although the epidemiologic literature regarding female breast cancer is extensive, relatively …

Archive ouverte UNIGE Incidence and outcome of male breast cancer: an international
population- based study Page 1 Archive ouverte UNIGE https://archive-ouverte.unige.ch Article …

Background The overall incidence of male breast cancer is around 1% of all breast cancers
and is on the rise. In this review we aim to present various aspects of male breast cancer …

Aims Male breast cancer incidence is 1% of all breast cancers and is increasing. We aim to
present an overview of male breast cancer with particular emphasis on clinical …

Context.—The rate of male breast cancer is a small fraction of that observed in females, thus
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …

To investigate at the population level the impact of BRCA1/BRCA2 gene alterations in male
breast cancer, we analyzed a population-based series of 25 male breast cancer cases from …

Male breast cancer is rare, and experience of it in any single institution is limited. Our current
understanding regarding its biology, natural history, and treatment strategies has been …

The current investigation was conducted to evaluate the proportional distribution of the
various histologic subtypes (including newly recognized variants) of male breast …